Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.

Boltz DA, Douangngeun B, Phommachanh P, Sinthasak S, Mondry R, Obert C, Seiler P, Keating R, Suzuki Y, Hiramatsu H, Govorkova EA, Webster RG.

J Gen Virol. 2010 Apr;91(Pt 4):949-59. doi: 10.1099/vir.0.017459-0. Epub 2009 Dec 16.

2.
3.

Advances in the structure-based design of the influenza A neuraminidase inhibitors.

Mitrasinovic PM.

Curr Drug Targets. 2010 Mar;11(3):315-26. Review.

PMID:
20210756
4.

Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.

Hayden F, Klimov A, Tashiro M, Hay A, Monto A, McKimm-Breschkin J, Macken C, Hampson A, Webster RG, Amyard M, Zambon M.

Antivir Ther. 2005;10(8):873-7. Review. Erratum in: Antivir Ther. 2006;11(1):130.

PMID:
16430192
5.

Computational studies of influenza A virus at three important targets: hemagglutinin, neuraminidase and M2 protein.

Rungrotmongkol T, Yotmanee P, Nunthaboot N, Hannongbua S.

Curr Pharm Des. 2011;17(17):1720-39. Review.

PMID:
21619529
6.

Emerging antiviral targets for influenza A virus.

Krug RM, Aramini JM.

Trends Pharmacol Sci. 2009 Jun;30(6):269-77. doi: 10.1016/j.tips.2009.03.002. Epub 2009 May 8. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk